Industry News
Fondo Alerce Invests US$1.4m in GeneproDX Spa (en español)
14 December 2017
Fondo Alerce made a US$1.4m investment in GeneproDX SPA, a Chilean biomedical startup working on thyroid cancer detection.
(LexLatin) La empresa chilena de biomedicina GeneproDX SPA recibió un aporte de USD 1.400.000 del Fondo de Inversión Privado Alerce VC para continuar con el desarrollo de un test de diagnóstico molecular del cáncer de tiroides, denominado ThyroidPrint, el cual permitirá eliminar los altos niveles de imprecisión en la detección de esta enfermedad.
Read more at LexLatin.
You may be interested in...
-
Lafise Deal Case; Advent, SoftBank and Valor Invest in Mexico and Brazil’s Merama
-
Patria Invests ~USD54.5m in Brazil’s Randoncorp
Patria Investments invested BRL320m (~USD54.5m) in Randoncorp, a Brazil-based holding...
-
CDPQ’s Verene Energia to Acquire Brazil’s Equatorial Transmissao for ~USD891.4m
CDPQ-backed Verene Energia to acquire Equatorial Transmissão, a Brazil-based power...
-
Macquarie Asset Management Acquires 45% Stake in Mexico’s TAG Pipelines Sur
Macquarie Asset Management agreed to acquire a 45% stake in TAG Pipelines Sur, a...